PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2207608

Oocyte donation and surrogacy.

P Serhal
View original source ↗Export metadata ↓

Abstract

Oocyte donation offers the prospect of achieving a successful pregnancy to a group of patients traditionally considered to be irreversibly sterile. In patients with ovarian failure, it is possible to create an endometrial milieu that is receptive to embryonic implantation by giving exogenous steroid replacement. A high fertility potential can be achieved with a low miscarriage rate in oocyte recipients irrespective of the patient's age. This reflects the improved biological performance of oocytes obtained from young donors. In oocyte recipients, it is now feasible to dissociate the stages of embryonic development and endometrial maturation. Hence, oocyte donation can provide insights into as yet unresolved questions such as the duration of the 'implantation window' in humans. Oocyte donation will undoubtedly complement basic IVF in trying to elucidate the biological interactions between the conceptus, endometrium and steroid environment in human reproduction.

Explore related subjects

Embryo ImplantationEmbryo TransferFemaleHumansMenstrual CycleOocytesPregnancyReproductive TechniquesGestational CarriersJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Serhal. 1990. Oocyte donation and surrogacy.. https://doi.org/10.1093/oxfordjournals.bmb.a072432

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Three-dimensional ultrasound assessment of endometrial receptivity: a review.

Three-dimensional ultrasound (3D US) is a new imaging modality, which is being introduced into clinical practice. Although this technique will not probably replace two-dimensional ultrasound, it is being increasingly used. It has been reported that 3D US is a very high reproducible technique. The endometrium has been paid special attention when using this technique. The aim of this paper is to address some technical aspects of 3D US and to review critically its current status in evaluating endometrial function with special focus in its role in predicting pregnancy in assisted reproductive techniques. In spontaneous cycles endometrial volume grows during follicular phase remaining constant through the luteal phase. Endometrial vascularization increases during follicular phase peaking 2-3 days before ovulation, decreasing thereafter and increasing again during mid and late luteal phase. Data from studies analysing the role of 3D US for predicting IVF outcome are controversial. An explanation for these controversial findings might be different design of reported studies, specially the timing of ultrasound evaluation.

Embryo Implantation↗
PubMed2006

Investigation and treatment of repeated implantation failure following IVF-ET.

Pregnancy rate following one cycle of IVF and ET can be as high as 60%. But even in the very successful units, some couples fail repeatedly. The causes for repeated implantation failure (RIF) may be because of reduced endometrial receptivity, embryonic defects or multifactorial causes. Various uterine pathologies, such as thin endometrium, altered expression of adhesive molecules and immunological factors, may decrease endometrial receptivity, whereas genetic abnormalities of the male or female, sperm defects, embryonic aneuploidy or zona hardening are among the embryonic reasons for failure of implantation. Endometriosis and hydrosalpinges may adversely influence both. In this mini review, we discuss the suggested methods for evaluation and treatment of RIF: repeated hysteroscopy, myomectomy, endometrial stimulation, immunotherapy, preimplantation genetic screening (PGS), assisted hatching, zygote intra-Fallopian transfer (ZIFT), co-culture, blastocyst transfer, cytoplasmic transfer, tailoring stimulation protocols and salpingectomy for hydrosalpinges.

Embryo Implantation↗
PubMed2006

Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure.

BACKGROUND: The objective of this study was to determine the incidence of undiagnosed thrombophilic factors and its relation to IVF and embryo transfer failure in women who have had three or more previous IVF-embryo transfer cycles. METHODS: The study group comprised of 90 consecutive women with three or more previously failed IVF-embryo transfer cycles (group A). Two control groups were enrolled: group B (n=90) included women who have had successful pregnancy after their first IVF-embryo transfer cycle, and group C (n=100) included women who conceived spontaneously with at least one uneventful pregnancy and no previous history of miscarriage. All women were tested for the presence of inherited [factor V Leiden (FVL) mutation, prothrombin mutation, methylenetetrahydrofolate reductase (MTHFR) mutation and deficiencies in proteins S and C and antithrombin III] or acquired (lupus anticoagulant and anticardiolipin) thrombophilic factors. RESULTS: An increase in the incidences of FVL, MTHFR and antiphospholipid antibodies was found in the study group compared with the two control groups. At least one inherited or acquired thrombophilic factor was detected in 68.9% of women with repeated IVF failure compared with 25.6 and 25% in the groups B and C, respectively (P<0.01). Combined thrombophilia (two or more thrombophilic factors) was significantly higher in women who have had repeated IVF failure as compared with the two control groups (35.6 versus 4.4 and 3%) (P<0.0001). CONCLUSION: Thrombophilia has a significant role in IVF-embryo transfer implantation failure. Women with repeated IVF-embryo transfer failure should be screened for thrombophilia.

Embryo Implantation↗